Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: Pooled analysis of KROG 10-01 and 11-02

Radiotherapy and Oncology

Volumn 113, Issue 1, 2014, Pages 18-23

  Lee, Jong Hoon ^a,g   Jang, Hong Seok ^a   Kim, Jun Gi ^b   Lee, Myung Ah ^a   Kim, Dae Yong ^c   Kim, Tae Hyun ^c   Oh, Jae Hwan ^c   Park, Sung Chan ^c   Kim, Sun Young ^c   Baek, Ji Yeon ^c   Park, Hee Chul ^d   Kim, Hee Cheol ^d   Nam, Taek Keun ^e   Chie, Eui Kyu ^f   Jung, Ji Han ^g   Oh, Seong Taek ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c National Cancer Center   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

Author keywords

MR imaging; Preoperative chemoradiotherapy; Rectal cancer; Restaging; Total mesorectal excision

Indexed keywords

CAPECITABINE; FLUOROURACIL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; DIAGNOSTIC ACCURACY; EXCISION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; ADJUVANT THERAPY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PREOPERATIVE CARE; PROCEDURES; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84915786236     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.016     Document Type: Article

References (23)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
2. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-23.
3. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-82.
4. Lezoche E, Baldarelli M, Lezoche G, et al. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 2012; 99: 1211-8.
5. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
6. Kim DJ, Kim JH, Lim JS, et al. Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. RadioGraphics 2010; 30: 503-16.
7. Lee JH, Kim SH, Kim JG, et al. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 2011; 82: 431-8.
8. Kuo LJ, Chern MC, Tsou MH, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005; 48: 23-8.
9. Chen CC, Lee RC, Lin JK, et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005; 48: 722-8.
10. Yeo SG, Oh JH, Kim DY, et al. Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01). Int J Radiat Oncol Biol Phys 2013; 86: 34-9.
11. Lee JH, Kim JG, Oh ST, et al. Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: a phase II multi-institutional clinical trial (KROG 11-02). Radiother Oncol 2014; 110: 150-4.
12. Taylor FG, Quirke P, Heald RJ, et al. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011; 98: 872-9.
13. Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982; 38: 143-51.
14. Iafrate F, Laghi A, Paolantonio P, et al. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings. RadioGraphics 2006; 26: 701-14.
15. Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008; 15: 729-37.
16. Kim JH, Beets GL, Kim MJ, et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004; 52: 78-83.
17. Borschitz T, Wachtlin D, Mohler M, et al. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008; 15: 712-20.
18. Patel UB, Brown G, Rutten H, et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012; 19: 2842-52.
19. Noh JM, Park W, Kim JS, et al. Outcome of local excision following preoperative chemoradiotherapy for clinically T2 distal rectal cancer: a multicenter retrospective study (KROG 12-06). Cancer Res Treat 2014; 46: 243-9.
20. Buijsen J, van den Bogaard J, Janssen MH, et al. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer. Radiother Oncol 2011; 98: 270-6.
21. Kremser C, Trieb T, Rudisch A, et al. Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging 2007; 26: 662-71.
22. Buijsen J, van den Bogaard J, van der Weide H, et al. FDG-PET-CT reduces the interobserver variability in rectal tumor delineation. Radiother Oncol 2012; 102: 371-6.
23. Yu M, Jang HS, Jeon DM, et al. Dosimetric evaluation of Tomotherapy and fourbox field conformal radiotherapy in locally advanced rectal cancer. Radiat Oncol J 2013; 31: 252-9.